(Q44282613)

1 December 2017

Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies (English)

1 reference

1 December 2017

Zoulim F

1

1 reference

1 December 2017

Berthillon P

2

1 reference

1 December 2017

Guerhier FL

3

1 reference

1 December 2017

Seigneres B

4

1 reference

1 December 2017

Germon S

5

1 reference

1 December 2017

Pichoud C

6

1 reference

1 December 2017

Cheng YC

7

1 reference

1 December 2017

Trepo C

8

1 reference

1 December 2017

1 December 2002

1 reference

Journal of Gastroenterology and Hepatology

1 December 2017

1 reference

1 December 2017

17 Suppl

1 reference

1 December 2017

S460-3

1 reference

A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA.

1 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Isolation of a hepadnavirus from the woolly monkey, a New World primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Lamivudine therapy of WHV-infected woodchucks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Hepatitis B virus transgenic mice: insights into the virus and the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S4.10.X

10.1046/J.1440-1746.17.S4.10.X

21 January 2018

Identifiers

DOI

1 reference

release_g3tjo6g3vrac7afz6kb7rupngm

1 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g3tjo6g3vrac7afz6kb7rupngm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference